4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-001554
Options or other derivatives
- Chief Executive Officer acquired 9,384 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ng George K Chief Executive Officer | 2026-07-26 | Grant or award · Restricted Stock Units | +9,384 | 21,224 | D | ||
Loading xslF345X06/form4.xml…